Skip to content

Astrana Health, Inc.: 10-Q filed 2016-11-14

What Astrana Health, Inc. reported in its quarterly report filed 2016-11-14 (fiscal Q2 2017): 31 published measures, 85 facts as tagged in accession 0001144204-16-134062.

This filing

Form
10-Q (quarterly report)
Filed
2016-11-14
Fiscal period
fiscal Q2 2017
Accession
0001144204-16-134062 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Astrana Health, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-09-3014,952,911USD
At 2016-03-3119,566,533USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-09-309,155,999USD
At 2016-03-3111,015,247USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-09-30-3,277,335USD
At 2016-03-31-1,269,427USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-09-303,793,502USD
At 2016-03-319,270,010USD
At 2015-09-303,924,922USD
At 2015-03-315,014,242USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2016-07-01 to 2016-09-30-1,358,409USD92
2016-04-01 to 2016-09-30-2,673,666USD183
2015-07-01 to 2015-09-30-531,366USD92
2015-04-01 to 2015-09-30-3,013,732USD183

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2016-04-01 to 2016-09-30205,775USD183
2015-04-01 to 2015-09-3042,572USD183

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2016-07-01 to 2016-09-3014,622,656USD92
2016-04-01 to 2016-09-3026,994,329USD183
2015-07-01 to 2015-09-3011,369,607USD92
2015-04-01 to 2015-09-3021,573,734USD183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-09-30-31,358,231USD
At 2016-03-31-28,684,565USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2016-07-01 to 2016-09-30-185,040USD92
2016-04-01 to 2016-09-30-226,593USD183
2015-07-01 to 2015-09-30-186,138USD92
2015-04-01 to 2015-09-30-93,447USD183

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-09-301,302,667USD
At 2016-03-311,247,973USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2016-07-01 to 2016-09-30-2,174,411USD92
2016-04-01 to 2016-09-30-3,936,876USD183
2015-07-01 to 2015-09-30-412,907USD92
2015-04-01 to 2015-09-30-2,077,604USD183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-09-309,112,887USD
At 2016-03-3113,558,497USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2016-07-01 to 2016-09-303,054USD92
2016-04-01 to 2016-09-305,713USD183
2015-07-01 to 2015-09-3068,818USD92
2015-04-01 to 2015-09-30429,220USD183

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-09-306,815,367USD
At 2016-03-317,431,780USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2016-09-301,622,483USD
At 2016-03-311,622,483USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2016-09-301,459,000USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2016-09-304,578,114USD
At 2016-03-313,392,941USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2016-07-01 to 2016-09-3016,797,067USD92
2016-04-01 to 2016-09-3030,931,205USD183
2015-07-01 to 2015-09-3011,782,514USD92
2015-04-01 to 2015-09-3023,651,338USD183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-09-306,033,518shares
At 2016-03-315,876,852shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2016-09-3024,190,118USD
At 2016-03-3123,524,517USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2016-09-30-1,280,866USD
At 2016-03-311,473,508USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2016-09-302,162,895USD
At 2016-03-312,353,212USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2016-09-30221,979USD
At 2016-03-31216,442USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2016-09-30430,278USD
At 2016-03-31293,828USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2016-07-01 to 2016-09-30-1,470,754USD92
2016-04-01 to 2016-09-30-2,370,132USD183
2015-07-01 to 2015-09-30-293,827USD92
2015-04-01 to 2015-09-30-2,524,331USD183

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2016-07-01 to 2016-09-304,455,329USD92
2016-04-01 to 2016-09-308,291,804USD183
2015-07-01 to 2015-09-303,440,641USD92
2015-04-01 to 2015-09-307,677,846USD183

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2016-07-01 to 2016-09-30170,555USD92
2016-04-01 to 2016-09-30335,213USD183
2015-07-01 to 2015-09-3077,684USD92
2015-04-01 to 2015-09-30141,435USD183

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2016-07-01 to 2016-09-3010,560USD92
2016-04-01 to 2016-09-3012,531USD183
2015-07-01 to 2015-09-30-95,092USD92
2015-04-01 to 2015-09-305,912USD183

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2016-07-01 to 2016-09-30518,617USD92
2016-04-01 to 2016-09-301,340,151USD183
2015-07-01 to 2015-09-30-67,058USD92
2015-04-01 to 2015-09-30-540,174USD183

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2016-04-01 to 2016-09-300USD183
2015-04-01 to 2015-09-306,129USD183

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2016-04-01 to 2016-09-301,254,806USD183
2015-04-01 to 2015-09-30214,131USD183

Inspect the source

Entity
Astrana Health, Inc. / CIK 0001083446
Captured
2026-09-20T05:20:50.832Z
SEC response SHA-256
24589a8b90ad6a7cdaab8fd1b252b61b042f4e45ec87312920857f7a3d1d7dfe

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001083446.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))